New shot could tame tough eczema in phase 2 trial
Disease control
Ongoing
This study tests an experimental drug called TRIV-509 in 95 adults with moderate to severe atopic dermatitis (eczema). Participants receive four doses of either TRIV-509 or a placebo, then switch to the other group. The goal is to see if TRIV-509 improves eczema symptoms and is s…
Phase: PHASE2 • Sponsor: Triveni Bio • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC